<code id='FF7ABB2A00'></code><style id='FF7ABB2A00'></style>
    • <acronym id='FF7ABB2A00'></acronym>
      <center id='FF7ABB2A00'><center id='FF7ABB2A00'><tfoot id='FF7ABB2A00'></tfoot></center><abbr id='FF7ABB2A00'><dir id='FF7ABB2A00'><tfoot id='FF7ABB2A00'></tfoot><noframes id='FF7ABB2A00'>

    • <optgroup id='FF7ABB2A00'><strike id='FF7ABB2A00'><sup id='FF7ABB2A00'></sup></strike><code id='FF7ABB2A00'></code></optgroup>
        1. <b id='FF7ABB2A00'><label id='FF7ABB2A00'><select id='FF7ABB2A00'><dt id='FF7ABB2A00'><span id='FF7ABB2A00'></span></dt></select></label></b><u id='FF7ABB2A00'></u>
          <i id='FF7ABB2A00'><strike id='FF7ABB2A00'><tt id='FF7ABB2A00'><pre id='FF7ABB2A00'></pre></tt></strike></i>

          knowledge

          knowledge

          author:knowledge    Page View:816
          Pharmacy shelves
          A conservative group advocating against changing how pharmacy middlemen operate spent more than $1 million on lobbying last quarter. GEORGE FREY/AFP via Getty Images

          WASHINGTON — A conservative group advocating against changing how pharmacy middlemen operate spent more than $1 million on lobbying last quarter — its highest-ever spend by far, according to federal filings.

          The Council for Citizens Against Government Waste spent $1.1 million on lobbying last quarter, and only employed a single lobbyist. That’s 22 times the $50,000 it spent in the same quarter last year. Its prior spending record was $700,000, from the start of 2020.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          focus

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          I learned firsthand about improving diversity in clinical trials
          I learned firsthand about improving diversity in clinical trials

          Asthebiopharmaceuticalindustryplacesincreasedemphasisonimprovingthediversityofparticipantsinclinical

          read more
          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more

          Medicare solvency divides Republicans at the presidential debate

          RepublicanpresidentialcandidateformerU.N.AmbassadorNikkiHaleyspeaksasformerNewJerseyGov.ChrisChristi